Healthcare stocks have rebounded to a degree since the start of 2023, but a wide swath of these equities are still trading well below their all-time highs following the 2022 bear market. A small handful of healthcare stocks, however, have managed to defy this downward trend. 

For example, GE Healthcare Technologies (NASDAQ: GEHC) and Reata Pharmaceuticals (NASDAQ: RETA) have actually been thriving in this harsh climate for healthcare equities. Specifically, GE Healthcare stock has risen by a stately 31.3% through the first two months of 2023, while Reata's shares have gapped up by an eye-catching 133% over this same period.

Are these two shining stars in the out-of-favor healthcare sector still worth buying? Let's dig deeper to find out. 

Continue reading

Source Fool.com